Garden Stage Limited Ordinary Shares (GSIW)
Filed: 30 Nov 23, 8:59pm
As filed with the U.S. Securities and Exchange Commission on November 30, 2023
Registration No. 333-[ ]
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-1
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
Garden Stage Limited
(Exact name of registrant as specified in its charter)
| Cayman Islands | 6199 | Not Applicable | ||
| (State or other jurisdiction of incorporation or organization) | (Primary Standard Industrial Classification Code Number) | (I.R.S. Employer Identification Number) |
Room 201, 2/F, China Insurance Group Building
141 Des Voeux Road Central
Central, Hong Kong
Tel: +852 2688 6333
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
c/o Cogency Global Inc.
122 East 42nd Street, 18th Floor
New York, NY 10168
+1(800) 221-0102
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copies to:
| William S. Rosenstadt, Esq. Mengyi “Jason” Ye, Esq. Ortoli Rosenstadt LLP 366 Madison Avenue, 3rd Floor New York, NY 10017 +1-212-588-0022 – telephone | Mark E. Crone, Esq. Liang Shih, Esq. The Crone Law Group P.C. 420 Lexington Avenue, Suite 2446 New York, NY 10170 +1-646-861-7891 – telephone |
Approximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement becomes effective.
If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☐
If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☒ (File No. 333-273053)
If this form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
Emerging growth company ☒
If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
The Registration Statement shall become effective upon filing with the Securities and Exchange Commission in accordance with Rule 462(b) promulgated under the Securities Act of 1933, as amended.
EXPLANATORY NOTE AND INCORPORATION BY REFERENCE
This Registration Statement on Form F-1 (this “Registration Statement”) is being filed pursuant to Rule 462(b) under the Securities Act of 1933, as amended, for the sole purpose of increasing the aggregate number of ordinary shares offered by GARDEN STAGE LIMITED (the “Registrant”) by 575,000 ordinary shares of the Registrant (including 75,000 ordinary shares upon the exercise by the underwriters of their over-allotment option). The additional securities that are being registered for sale are in an amount and at a price that together represent no more than 20% of the maximum aggregate offering price set forth in the Calculation of Registration Fee table contained in the Registration Statement on Form F-1, as amended (File No. 333-273053) (the “Prior Registration Statement”), initially filed with the Securities and Exchange Commission (the “Commission”) on June 30, 2023, which was declared effective by the Commission on November 30, 2023. The information set forth in the Prior Registration Statement and all exhibits thereto are hereby incorporated by reference in this filing.
The required opinion and consents are listed on an Exhibit Index attached hereto and filed herewith.
EXHIBIT INDEX
| EXHIBIT NUMBER | EXHIBIT DESCRIPTION | |
| 5.1 | Opinion of Traver Thorp Alberga regarding the validity of the securities being registered | |
| 23.1 | Consent of Traver Thorp Alberga (included in Exhibits 5.1) | |
| 23.2 | Consent of Friedman LLP | |
| 23.3 | Consent of Marcum Asia CPAs LLP | |
| 107 | Filing Fee Table |
II-1
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hong Kong on November 30, 2023.
| GARDEN STAGE LIMITED | ||
| By: | /s/ Sze Ho, CHAN | |
| Sze Ho, CHAN | ||
| Chief Executive Officer (Principal Executive Officer) | ||
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
| Name | Title | Date | ||
| /s/ Sze Ho, CHAN | Chief Executive Officer and Director | November 30, 2023 | ||
| Sze Ho, CHAN | (Principal Executive Officer) | |||
| /s/ Wai Lok Raymond, FONG | Director | November 30, 2023 | ||
| Wai Lok Raymond, FONG | ||||
| /s/ Ngan Sammy, SHUM | Director | November 30, 2023 | ||
| Ngan Sammy, SHUM | ||||
| /s/ Ting Hei, LEE | Chief Financial Officer | November 30, 2023 | ||
| Ting Hei, LEE | (Principal Financial and Accounting Officer) |
II-2
SIGNATURE OF AUTHORIZED AGENT IN THE UNITED STATES
Pursuant to the Securities Act of 1933 as amended, the undersigned, the duly authorized agent in the United States of America, has signed this registration statement thereto in New York, NY on November 30, 2023.
| Authorized U.S. Representative — Cogency Global Inc. | ||
| By: | /s/ Colleen A. De Vries | |
| Name: | Colleen A. De Vries | |
| Title: | Senior Vice-President on behalf of Cogency Global Inc. | |
II-3